Patents by Inventor Malcolm Moon

Malcolm Moon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • (5R)-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione and method of preparation thereof
    Publication number: 20060040929
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) in a dosage range where the sexually therapeutic amount is from about 0.2 thru 8 mg/person/dose and where the sexually mating amount is from about 0.003 thru 0.2 mg/kg/dose. The present invention also provides a novel pharmaceutical agent, (5R)-5 -(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: July 27, 2005
    Publication date: February 23, 2006
    Inventors: Robert McCall, Martin Meglasson, Brad Acker, Richard Heier, Alan Jin, Malcolm Moon
  • Quaternary ammonium compounds
    Publication number: 20050148672
    Abstract: The compound 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol may be used to prepare the compound (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide by reaction with methyl bromide.
    Type: Application
    Filed: March 8, 2005
    Publication date: July 7, 2005
    Inventors: Ivan Richards, Sue Cammarata, Craig Wegner, Michael Hawley, Mark Warchol, Mark Kontny, Walter Morozowich, Karen Kolbasa, Malcolm Moon, Dominique Bonafoux, Sergey Wolfson, Patrick Lennon
  • Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
    Publication number: 20050107340
    Abstract: The present invention is directed to prodrugs of certain 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives that modulate the activity of protein kinases (“PKs”). Pharmaceutical compositions comprising these compounds, methods of treating diseases related to abnormal PK activity utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
    Type: Application
    Filed: February 10, 2004
    Publication date: May 19, 2005
    Inventors: Malcolm Moon, Walter Morozowich, Ping Gao, Marcel Koenig